A Prospective Randomised Case Control Study on the Role of Probiotics in Controlling Chronic Kidney Disease Progression

Aim: To study the role of probiotics in controlling chronic kidney disease progression.

Sample: To correlate renal parameters like creatinine, urea, uric acid, PCR in patients with chronic kidney disease.

Study Design: It is a Prospective case control study

Place and Duration of the Study: Department of Nephrology, Santhiram Medical college and General Hospital, between December 2020 – May 2021.

Methodology: We included 150 patients with chronic kidney disease from in and out patient departments. In this study patients are divided into two groups; case and control group. Control group is treated with normal conventional therapy whereas the case group is treated with conventional therapy along with probiotics. The lab parameters like creatinine, PCR, urea, uric acid were analyzed before and after the therapy in both groups.

Results: The lab parameters were analyzed by paired student`s t- test and the p value of these parameters were found to be in control group creatinine ranges from (4.42+/- 2.84 to 3.54+/- 2.73) and in case/ interventional group creatinine ranges from (5.13+/-2.43 to 2.29+/-1.57) shows <0.001. It shows significant improvement in these parameters in both control and case group. CKD stages were analyzed by Chi- square test, the p value of CKD stages in case group was found to be <0.0001 and in control group it was found to be 0.03.

Conclusion: It shows that there is significant improvement is found in both interventional (case) and non-interventional (control) groups. But more betterment is observed in case group than in control group. Hence probiotics are used as a natural bio-treatment to control the progression of CKD and improves the quality of life.